Announce Date | 02/26/2025 |
EPS Normalized Actual | $0.16 (Beat by $0.08) |
EPS GAAP Actual | $0.16 (Beat by $0.08) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.45 |
EPS GAAP Estimate | $0.45 |
Revenue Estimate | $2.2015B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 1.53 | 9.64 | 1.51312 | 1.55111 | 1 |
Dec 2026 | 1.58 | 9.33 | 1.53047 | 1.72213 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0 | -0.1 | 0B | NAN% | -2037.69M |
FQ3 2024 (Sep 2024) | 0.15 | -1.39141 | 2.06241B | 100% | -2755.23M |
FQ2 2024 (Jun 2024) | 0.84 | -0.50259 | 2.12409B | 100% | -2158.26M |
FQ3 2012 (Sep 2012) | 0.0177 | 0.0177 | 0.782265B | 100% | 782.27M |
FQ4 2012 (Dec 2012) | 0.0181 | 0.0181 | 0.8031B | 100% | 803.1M |
FQ1 2013 (Mar 2013) | 0.0258 | 0.0258 | 0.879751B | 100% | 879.75M |
FQ2 2013 (Jun 2013) | 0.0262 | 0.0262 | 0.89256B | 100% | 892.56M |
FQ3 2013 (Sep 2013) | 0.0361 | 0.0361 | 0.855714B | 8.58% | 855.71M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.45
Consensus Revenue Estimates
2.2015B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.21395 | -- | 0.21221 | 0.2158 | 1 |
FQ3 2026 (Sep 2026) | 0.29456 | -- | 0.29216 | 0.29711 | 1 |
FQ2 2026 (Jun 2026) | 0.56808 | -- | 0.56346 | 0.573 | 1 |
FQ1 2026 (Mar 2026) | 0.47667 | -- | 0.47279 | 0.4808 | 1 |
FQ4 2025 (Dec 2025) | 0.18 | -- | 0.17867 | 0.18136 | 1 |
FQ3 2025 (Sep 2025) | 0.27 | 44.44 | 0.25687 | 0.29634 | 1 |
FQ2 2025 (Jun 2025) | 0.45 | -86.67 | 0.42811 | 0.4939 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 2.16B | -- | 2.15B | 2.18B | 1 |
FQ3 2026 (Sep 2026) | 2.13B | -- | 2.12B | 2.15B | 1 |
FQ2 2026 (Jun 2026) | 2.19B | -- | 2.18B | 2.21B | 1 |
FQ1 2026 (Mar 2026) | 2.06B | -- | 2.05B | 2.08B | 1 |
FQ4 2025 (Dec 2025) | 2.11B | -- | 2.09B | 2.12B | 0 |
FQ3 2025 (Sep 2025) | 2.1B | 2.01 | 2.03B | 2.26B | 0 |
FQ2 2025 (Jun 2025) | 2.2B | 3.52 | 2.12B | 2.37B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.1 | 0 | -0.1 | -INF% |
FQ3 2024 (Sep 2024) | 1.54141 | 0.15 | -1.39141 | -927.61% |
FQ2 2024 (Jun 2024) | 1.34259 | 0.84 | -0.50259 | -59.83% |
FQ3 2012 (Sep 2012) | 0.0177 | 0.0177 | 100% | |
FQ4 2012 (Dec 2012) | 0.0181 | 0.0181 | 100% | |
FQ1 2013 (Mar 2013) | 0.0258 | 0.0258 | 100% | |
FQ2 2013 (Jun 2013) | 0.0262 | 0.0262 | 100% | |
FQ3 2013 (Sep 2013) | 0.0361 | 0.0361 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $2.04B | $0B | $-2037.69M | -INF% |
FQ3 2024 (Sep 2024) | $4.82B | $2.06B | $-2755.23M | -133.59% |
FQ2 2024 (Jun 2024) | $4.28B | $2.12B | $-2158.26M | -101.61% |
FQ3 2012 (Sep 2012) | $0B | $0.78B | $782.27M | 100% |
FQ4 2012 (Dec 2012) | $0B | $0.8B | $803.1M | 100% |
FQ1 2013 (Mar 2013) | $0B | $0.88B | $879.75M | 100% |
FQ2 2013 (Jun 2013) | $0B | $0.89B | $892.56M | 100% |
FQ3 2013 (Sep 2013) | $0B | $0.86B | $855.71M | 100% |